We have been studying
I have been interested in the biology of glial cells. According to the traditionally accepted view, the adult mammalian central nervous system (CNS) consists of the following cell types.1 Neurons are the major play ers, in the sense that they are the only cell type that can generate action potentials. Glial cells have been con sidered to be supporting cells, although they far exceed neurons in number. Macroglial cells, which arise from the neuroectoderm, consist of astrocytes and oligo dendrocytes. Oligodendrocytes make myelin sheaths around axons, allowing fast saltatory conduction of action potentials. Astrocytes carry out various func tions. For example, they take up excess potassium ions generated by neuronal activity. In addition to these macroglial cells, there are microglial cells that arise in the bone marrow and take up residence in the CNS during development. We have been studying a pop ulation of glial cells whose properties are different from those of any of the cells described above. These cells can be identified with an antibody against a cell surface proteoglycan called NG2. A culture system to study the development of oligo dendrocytes was established by Martin Raff and col leagues fifteen years ago.8 They used the antibody to the A2B5 gangliosides to identify progenitor cells in vitro. In serum-free medium, A2B5+ progenitor cells differentiate into mature oligodendrocytes. As they dif ferentiate, they lose the A2B5 immunoreactivity and first acquire the expression O4 glycolipids. With further differentiation, they begin to express various myelin components such as galactocerebroside (GC), myelin basic protein (MBP), and proteolipid protein (PLP). As they differentiate, they change their morphology from a simple, bipolar cell to one with highly branched pro cesses. Numerous studies have been carried out in vitro to identify growth factors that regulate proliferation and differentiation of oligodendrocyte progenitor cells. Studies done mainly by Bill Richardson and colleagues have shown that the AA isoform of platelet-derived growth factor (PDGF AA) is the major mitogen for progenitor cells. PDGF AA mediates its effects through the a receptor expressed by the progenitor cells, as demonstrated by in situ hybridization and ligand bind ing studies. [9] [10] [11] As an initial step in understanding the role of NG2 in the development of these cells, we compared the expression of NG2 and PDGFa receptor at the protein level by immunocytochemistry using anti-NG2 anti bodies generated in Bill Stallcup's laboratory and anti PDGFa receptor antibodies kindly provided by Neill Giese (COR Therapeutics, CA), Charles Hart (Zymo Genetics, WA), and Carl-Henrik Heldin (Uppsala Uni versity, Sweden). NG2 is present on bipolar cells that are also immunoreactive for the progenitor marker A2B5 and is co-localized with PDGFa receptor on the progenitor cells. When the cells are allowed to differ entiate into oligodendrocytes, they lose NG2 expression and acquire the expression of O4 antigens followed by the expression of GC and myelin proteins. PDGFa receptor is also downregulated at the same time as NG2. Thus, in vitro, both NG2 and PDGFa receptor are co-localized on oligodendrocyte progenitor cells and are down-regulated as they differentiate into mature oligodendrocytes.12 Neither NG2 nor PDGFa receptor can be detected on astrocytes, microglial cells, or neurons. Thus the two cell surface molecules appear to be expressed specifically by oligodendrocyte progen itor cells among cells in the CNS parenchyma.
NG2 is Expressed by

NG2+ Cells in vivo
Using the two antigens that are specifically expressed by oligodendrocyte progenitor cells in vitro, we pro ceeded to examine the distribution of NG2+/PDGFa receptor+ cells in the developing rat brain in vivo. 13 The earliest immunoreactive cells which appear in the ventral ventricular zone of the rat spinal cord at embryonic day 15 (E15) express PDGFa receptor but not NG2. Similarly PDGFa receptor-positive, NG2 negative cells are found in the subventricular zone of the cerebrum around E17. These cells then migrate out into the parenchyma, and as soon as they leave the ventricular zone, they begin to express NG2 as well as PDGFa receptor. They rapidly increase in number and fill up the entire CNS during the next two weeks and reach a maximum density during the first postnatal week. This is consistent with previously published development of cells of the oligodendrocyte line age. 10, 14-17 By this time, the entire CNS is filled with NG2+/PDGFa receptor+ cells. All the immuno reactive cells in the parenchyma co-express the two molecules. In contrast, many cells in the subventricular zone express PDGFa receptor but not NG2.
To determine whether the NG2+ cells differentiate into oligodendrocytes, we double-labeled postnatal day 7 (P7) rat brain sections for NG2 and PLP, which is expressed by differentiated oligodendrocytes. While the majority of the NG2+ cells do not express PLP, one can detect rare cells that weakly express both NG2 and PLP. 18 Similarly, a small fraction of NG2+ cells at this age can be double-labeled with antibody to GC19 or MBP.13 This suggests that there is a transition from an NG2+ cell into an oligodendrocyte. Thus we have shown that the pattern of antigenic expression in vivo is quite similar to that in vitro, i.e. early progenitor cells express both NG2 and PDGFa receptor, but once they differentiate into mature oligodendrocytes that express myelin genes, the expression of both NG2 and PDGFa receptor is down-regulated.
During the course of these developmental studies , we noticed that the NG2+ cells do not disappear as the brain matures but remain in large numbers in the adult brain. Numerous NG2+ cells with complex processes exist uniformly throughout the gray and white matter of the mature CNS. The density of NG2+ cells is lower than that in the perinatal rat CNS , but their processes are more arborized and appear to cover the entire brain parenchyma. What are the numerous NG2+ cells in the mature brain? Extensive double-immunolabeling stud ies indicate that NG2+ cells are distinct from microglia or mature astrocytes that express glial fibrillary acidic protein. 19 .20 Yet they constitute such a significant pop-ulation in the adult mammalian CNS, existing in num bers comparable to or greater than mature oligoden drocytes, astrocytes or microglia, that one might call them the third major macroglial cell type. 
